An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
Public ClinicalTrials.gov record NCT02235909. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Study identification
- NCT ID
- NCT02235909
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Arbor Pharmaceuticals, Inc.
- Industry
- Enrollment
- 377 participants
Conditions and interventions
Conditions
Interventions
- Azilsartan Medoxomil Low-dose Drug
- Losartan Drug
- Placebo for Azilsartan Medoxomil Drug
- Placebo for Losartan Drug
- Azilsartan Medoxomil Medium-dose (20 mg) Drug
- Azilsartan Medoxomil High-dose (40 mg) Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 29, 2015
- Primary completion
- Nov 10, 2019
- Completion
- Nov 10, 2019
- Last update posted
- Feb 24, 2025
2015 – 2019
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Research Center, INC | Anaheim | California | 92805 | — |
| Direct Helpers Research Center | Hialeah | Florida | 33012 | — |
| JDH Medical Group LLC | Miami | Florida | 33125 | — |
| University of Miami/Jackson Memorial Hospital | Miami | Florida | 33136 | — |
| Medical Research Center of Miami II, Inc. | Miami | Florida | 33144 | — |
| Pioneer Clinical Research | North Miami | Florida | 33162 | — |
| Georgia Clinical Research | Snellville | Georgia | 30078 | — |
| Zoe Center for Pediatrics | Thomaston | Georgia | 30286 | — |
| University of Louisville | Louisville | Kentucky | 40202 | — |
| David M. Headley, MD PA | Port Gibson | Mississippi | 39150 | — |
| Mount Sinai PRIME | Lake Success | New York | 10029 | — |
| Medical University of South Carolina (MUSC) | Charleston | South Carolina | 29425 | — |
| Memphis and Shelby County Pediatric Group | Memphis | Tennessee | 38116 | — |
| Southeast Texas Clinical Research Center | Beaumont | Texas | 77701 | — |
| Texas Children's Heart Center | Houston | Texas | 77030 | — |
| Ericksen Research & Development, LLC | Clinton | Utah | 84015 | — |
| Mid-Columbia Research | Richland | Washington | 99352 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02235909, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 24, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02235909 live on ClinicalTrials.gov.